This systematic review and meta-analysis provide robust evidence that GLP-1 RAs are highly effective for producing clinically significant weight loss and improving multiple cardiometabolic outcomes in individuals with overweight or obesity. This evidence concerns the gene GLP1R and obesity disorder.